63 phenotypes from 6 alleles in 8 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Ank2em1Bnt/Ank2+ C57BL/6J-Ank2em1Bnt	abnormal axon morphology	J:277752
	normal behavior/neurological phenotype	J:277752
	enhanced spatial learning	J:277752
Ank2em1Bnt/Ank2em1Bnt C57BL/6J-Ank2em1Bnt	abnormal axon morphology	J:277752
	abnormal brain morphology	J:277752
	abnormal excitatory synapse morphology	J:277752
	abnormal miniature excitatory postsynaptic currents	J:277752
	abnormal social/conspecific interaction behavior	J:277752
	normal behavior/neurological phenotype	J:277752
	decreased locomotor activity	J:277752
	decreased paired-pulse facilitation	J:277752
	decreased vocalization	J:277752
	enhanced spatial learning	J:277752
	increased grooming behavior	J:277752
	increased miniature excitatory postsynaptic current amplitude	J:277752
	increased miniature excitatory postsynaptic current frequency	J:277752
	normal taste/olfaction phenotype	J:277752
Ank2em1Melr/Ank2em1Melr B6.Cg-Ank2em1Melr	abnormal heart echocardiography feature	J:338515
	abnormal myocardial fiber physiology	J:338515
	cardiac fibrosis	J:338515
	decreased cardiac muscle contractility	J:338515
	decreased heart rate	J:338515
	increased response of heart to induced stress	J:338515
	irregular heartbeat	J:338515
	prolonged QT interval	J:338515
	prolonged RR interval	J:338515
	sinus bradycardia	J:338515
Ank2tm1Bnt/Ank2+ involves: 129	abnormal fat cell differentiation	J:222913
	abnormal physiological response to xenobiotic	J:163867
	abnormal sinoatrial node conduction	J:163867
	decreased adipocyte glucose uptake	J:222913
	increased heart rate variability	J:163867
Ank2tm1Bnt/Ank2tm1Bnt B6.129-Ank2tm1Bnt/Bnt	abnormal social/conspecific interaction behavior	J:277752
	decreased vocalization	J:277752
	enhanced spatial learning	J:277752
Ank2tm1Bnt/Ank2tm1Bnt involves: 129	normal nervous system phenotype	J:186168
Ank2tm1Bnt/Ank2tm1Bnt involves: 129X1/SvJ * C57BL/6	abnormal anterior corticospinal tract morphology	J:52124
	abnormal axon morphology	J:52124
	abnormal lateral corticospinal tract morphology	J:52124
	abnormal locomotor behavior	J:52124
	decreased body weight	J:52124
	decreased brain internal capsule size	J:52124
	decreased corpus callosum size	J:52124
	disorganized secondary lens fibers	J:52124, J:70385
	enlarged lateral ventricles	J:52124
	impaired balance	J:52124
	neonatal lethality, incomplete penetrance	J:52124
	optic nerve degeneration	J:52124
	postnatal lethality, complete penetrance	J:52124
Ank2tm2.1Bnt/Ank2+ STOCK Ank2tm2Bnt/J	impaired glucose tolerance	J:222913
	premature death	J:222913
Ank2tm2.1Bnt/Ank2tm2.1Bnt STOCK Ank2tm2Bnt/J	abnormal fat cell differentiation	J:222913
	abnormal gluconeogenesis	J:222913
	normal behavior/neurological phenotype	J:222913
	normal homeostasis/metabolism phenotype	J:222913
	impaired glucose tolerance	J:222913
	increased adipocyte glucose uptake	J:222913
	increased body weight	J:222913
	increased circulating free fatty acids level	J:222913
	increased circulating glucose level	J:222913
	increased epididymal fat pad weight	J:222913
	increased fat cell size	J:222913
	increased susceptibility to age related obesity	J:222913
	increased susceptibility to diet-induced hepatic steatosis	J:222913
	increased susceptibility to diet-induced obesity	J:222913
	insulin resistance	J:222913
	normal muscle phenotype	J:222913
Ank2tm3.1Bnt/Ank2+ B6.129(C)-Ank2tm3.1Bnt/J	impaired glucose tolerance	J:222913
	increased circulating glucose level	J:222913
	increased susceptibility to age related obesity	J:222913
	premature death	J:222913
Ank2tm3.1Bnt/Ank2tm3.1Bnt B6.129(C)-Ank2tm3.1Bnt/J	abnormal fat cell differentiation	J:222913
	abnormal gluconeogenesis	J:222913
	abnormal glucose homeostasis	J:222913
	normal behavior/neurological phenotype	J:222913
	decreased adipocyte glucose uptake	J:222913
	decreased circulating insulin level	J:222913
	decreased insulin secretion	J:222913
	decreased muscle cell glucose uptake	J:222913
	normal homeostasis/metabolism phenotype	J:222913
	impaired glucose tolerance	J:222913
	increased adipocyte glucose uptake	J:222913
	increased body weight	J:222913
	increased circulating free fatty acids level	J:222913
	increased circulating glucose level	J:222913
	increased epididymal fat pad weight	J:222913
	increased fat cell size	J:222913
	increased muscle cell glucose uptake	J:222913
	increased susceptibility to age related obesity	J:222913
	increased susceptibility to diet-induced hepatic steatosis	J:222913
	increased susceptibility to diet-induced obesity	J:222913
	increased total body fat amount	J:222913
	insulin resistance	J:222913
Ank2tm4.1Bnt/Ank2+ Tg(Nes-cre)1Kln/0 B6.Cg-Ank2tm4.1Bnt Tg(Nes-cre)1Kln	abnormal axon morphology	J:277752
	abnormal social/conspecific interaction behavior	J:277752
	decreased vocalization	J:277752
	enhanced spatial learning	J:277752